Position effect, cryptic complexity, and direct gene disruption as disease mechanisms in <i>de novo</i> apparently balanced translocation cases by Aristidou, Constantia et al.
u n i ve r s i t y  o f  co pe n h ag e n  
Københavns Universitet
Position effect, cryptic complexity, and direct gene disruption as disease mechanisms
in de novo apparently balanced translocation cases
Aristidou, Constantia; Theodosiou, Athina; Bak, Mads; Mehrjouy, Mana M.; Constantinou,
Efthymia; Alexandrou, Angelos; Papaevripidou, Ioannis; Christophidou-Anastasiadou,
Violetta; Skordis, Nicos; Kitsiou-Tzeli, Sophia; Tommerup, Niels; Sismani, Carolina
Published in:
PLOS ONE
DOI:
10.1371/journal.pone.0205298
Publication date:
2018
Document version
Publisher's PDF, also known as Version of record
Document license:
CC BY
Citation for published version (APA):
Aristidou, C., Theodosiou, A., Bak, M., Mehrjouy, M. M., Constantinou, E., Alexandrou, A., ... Sismani, C. (2018).
Position effect, cryptic complexity, and direct gene disruption as disease mechanisms in de novo apparently
balanced translocation cases. PLOS ONE, 13(10), [e0205298]. https://doi.org/10.1371/journal.pone.0205298
Download date: 03. Feb. 2020
RESEARCH ARTICLE
Position effect, cryptic complexity, and direct
gene disruption as disease mechanisms in de
novo apparently balanced translocation cases
Constantia Aristidou1,2, Athina TheodosiouID1, Mads Bak3, Mana M. Mehrjouy3,
Efthymia Constantinou1, Angelos Alexandrou1, Ioannis Papaevripidou1,
Violetta Christophidou-Anastasiadou4, Nicos Skordis5,6, Sophia Kitsiou-Tzeli7,
Niels Tommerup3, Carolina SismaniID1,2*
1 Department of Cytogenetics and Genomics, The Cyprus Institute of Neurology and Genetics, Nicosia,
Cyprus, 2 The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology and Genetics,
Nicosia, Cyprus, 3 Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and
Molecular Medicine, University of Copenhagen, Copenhagen N., Denmark, 4 Department of Clinical
Genetics, The Cyprus Institute of Neurology and Genetics and Archbishop Makarios III Medical Centre,
Nicosia, Cyprus, 5 Division of Pediatric Endocrinology, Paedi Center for Specialized Pediatrics, Nicosia,
Cyprus, 6 St George’s University of London Medical School at the University of Nicosia, Nicosia, Cyprus,
7 Department of Medical Genetics, Medical School, University of Athens, Athens, Greece
* csismani@cing.ac.cy
Abstract
The majority of apparently balanced translocation (ABT) carriers are phenotypically normal.
However, several mechanisms were proposed to underlie phenotypes in affected ABT
cases. In the current study, whole-genome mate-pair sequencing (WG-MPS) followed by
Sanger sequencing was applied to further characterize de novo ABTs in three affected indi-
viduals. WG-MPS precisely mapped all ABT breakpoints and revealed three possible under-
lying molecular mechanisms. Firstly, in a t(X;1) carrier with hearing loss, a highly skewed X-
inactivation pattern was observed and the der(X) breakpoint mapped ~87kb upstream an X-
linked deafness gene namely POU3F4, thus suggesting an underlying long-range position
effect mechanism. Secondly, cryptic complexity and a chromothripsis rearrangement was
identified in a t(6;7;8;12) carrier with intellectual disability. Two translocations and a hetero-
zygous deletion disrupted SOX5; a dominant nervous system development gene previously
reported in similar patients. Finally, a direct gene disruption mechanism was proposed in a t
(4;9) carrier with dysmorphic facial features and speech delay. In this case, the der(9) break-
point directly disrupted NFIB, a gene involved in lung maturation and development of the
pons with important functions in main speech processes. To conclude, in contrast to familial
ABT cases with identical rearrangements and discordant phenotypes, where translocations
are considered coincidental, translocations seem to be associated with phenotype presenta-
tion in affected de novo ABT cases. In addition, this study highlights the importance of inves-
tigating both coding and non-coding regions to decipher the underlying pathogenic
mechanisms in these patients, and supports the potential introduction of low coverage WG-
MPS in the clinical investigation of de novo ABTs.
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Introduction
The great majority of apparently balanced translocation (ABT) cases are phenotypically nor-
mal since theoretically there is no obvious loss or gain of genetic material. However, associa-
tion with specific clinical phenotypes has been originally estimated in 6–10% of de novo ABT
cases [1], while recent studies assessing long-term outcomes in de novo ABT carriers estimated
a morbidity risk of 27% [2].
Many molecular mechanisms have been suggested to account for clinical phenotypes
observed in ABT carriers. First of all, this may be due to direct disruption of dosage-sensitive
genes [3], which also exhibit haploinsufficiency [4]. Apart from direct protein-coding gene dis-
ruption, ABT breakpoints can also map in intragenic areas, and may affect the regulation of
nearby genes by disrupting cis-regulatory elements, such as enhancers, through long-range
position effect (LRPE) [5,6]. For example, ABTs may affect the regulatory landscape of genes
by disrupting highly-conserved topologically associated domains (TADs) [7] within which
physical contact of genes and their regulators is achieved, via chromatin looping, for correct
expression to occur [8]. Specifically, a translocation can remove an enhancer/silencer from its
target gene or place a gene next to an enhancer/silencer that is not its own, therefore leading to
gene repression, overexpression, or ectopic expression. A third mechanism underlying pheno-
type presentation in ABT carriers is the presence of cryptic genomic imbalances near the trans-
location breakpoints or elsewhere in the genome [9,10], or the presence of complex
chromosomal rearrangements (CCRs) [9–11]. Other rarer molecular mechanisms include dis-
ruption of an imprinting locus in uniparental disomy (UPD) cases [12], unmasking of reces-
sive gene variants by loss-of-function at the translocation breakpoints leading to functional
homozygosity [13], as well as gene fusion generation which may result in a novel, non-func-
tional or pathogenic protein [14]. Finally, the presented phenotypes in ABT carriers may be
unrelated to the translocation and simply coincidental [15].
Detailed characterization of translocations and accurate breakpoint mapping in affected
ABTs carriers are crucial for positioning disease-candidate genes at or near the breakpoints
[16]. The overall purpose of this study was the use of Whole-Genome Mate-Pair Sequencing
(WG-MPS) (low coverage) to decipher the pathogenic molecular mechanisms underlying phe-
notype associations in three affected de novo ABT cases. Based on the results, a causative link
between translocation rearrangements and phenotype presentation in affected de novo ABT
carriers was established.
Materials and methods
Bioethics statement and consent form collection
This study was approved by the National bioethics committee as part of the Translation Facil-
ity Application with number EEBK/EII/2-13/09. Written informed consent was obtained from
all patients prior to initiation of the study.
Whole-genome mate-pair sequencing and translocation validation
In the current study, 1μg of high quality DNA sample from each ABT case was used to prepare
WG-MPS libraries (~2-4kb insert length) by following the Nextera Mate-Pair Sample Prepara-
tion Guide, gel-free protocol (Part #15035209 Rev.C) from Illumina (http://www.illumina.
com/). WG-MPS library preparation, library pooling, sequencing on an Illumina HiSeq2500
system, data analysis and filtering, translocation breakpoint validation, as well as LRPE investi-
gation were performed as described previously [15]. PCR primers used for translocation
breakpoint validation are available in S1 Table.
Disease mechanisms in de novo apparently balanced translocations
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Depth of coverage analysis
In order to identify any imbalances as a change in the depth of coverage of the WG-MPS
paired-end reads, the WG-MPS aligned files from selected samples were used as an input in
the cnv tool incorporated in the SVDetect software [17]. This tool calculates depth of coverage
log ratios from an affected (patient) and a non-affected (reference) sample. The log ratio data
were then used as input in order to create density plots in CIRCOS, a software package to visu-
alize data in circular output [18].
X-inactivation analysis
The X-chromosome inactivation status in a female patient (Case 1) carrying an X:autosome
translocation was determined by methylation analysis of the human androgen receptor (AR)
gene at Xq11.2, as described previously [19]. PCR products were run using a Fragment Analy-
sis protocol on a 3130xl Genetic Analyzer (Applied Biosystems), and X-inactivation analysis
results were analyzed by using the Microsatellite application of the GeneMapper v4.1 Software
(Applied Biosystems), according to the manufacturer’s instructions.
RNA extraction and DNase treatment
Total RNA from Epstein-Barr virus-transformed lymphoblastoid cell lines from patients and a
control sample was extracted with RNeasy Midi Kit (Qiagen, Hilden, Germany) following the
manufacturer’s instructions, and RNA concentration was measured with an ND-1000 Spectro-
photometer (Thermo Fisher Scientific, Waltham, MA, USA). For reverse transcription PCR
(RT-PCR) experiments, 10μg RNA was treated with DNase I (New England Biolabs (NEB),
Ipswich, MA, USA) to remove residual genomic DNA according to the manufacturer’s
protocol.
Reverse-transcription PCR primer design and procedure
RT-PCR primer pairs (Metabion, Planegg, Germany) were designed using the Primer3 web
interphase tool [20]. Wherever possible, forward and reverse primers were designed on two
consecutive exons spanning an intermediate large intron of the gene of interest. If a gene of
interest has only one protein-coding exon and no intermediate introns, RT-PCR primer pairs
were designed within the same exon. DNase-treated RNA (10pg-1μg) was reverse transcribed
using the ProtoScript First Strand cDNA Synthesis Kit (NEB) with oligo-dT primers, accord-
ing to the kit’s manual. ~50ng cDNA from each sample was amplified by 40 cycles of PCR
using pre-designed RT-PCR primer pairs within the genes of interest. An RNA sample not
reverse transcribed and a no template sample were used as negative controls. Finally the integ-
rity of the cDNA samples was shown by amplification of a 215bp fragment from the house-
keeping gene ACTB (β-actin). RT-PCR primer pairs and PCR conditions are available on
request.
Results
By using WG-MPS, translocation breakpoint junctions in all three affected de novo ABT carri-
ers included in the present study were successfully identified and mapped down to a region
ranging between 407bp and 1.9kb (Table 1). Direct and indirect disease-candidate gene dis-
ruption occurred in 2/3 and 1/3 cases, respectively, while cryptic complexity was identified in
1/3 cases. Microhomology (1-5bp) and imbalances (1-6bp) were also detected at the transloca-
tion breakpoint sites (Table 1). Detailed results are presented below:
Disease mechanisms in de novo apparently balanced translocations
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Case 1—46,X,t(X;1)(q13;p31)dn
Case 1 is a female patient with hearing loss and a de novo t(X;1)(q13;p31) translocation
(Fig 1A) as detected by previous karyotype and FISH analyses. WG-MPS followed by Sanger
sequencing accurately identified and mapped both translocation breakpoints (Fig 1B; Table 1).
The der(1) breakpoint disrupted the non-pathogenic leucine rich repeats and IQ motif con-
taining 3 (LRRIQ3) gene (intron 7/7) (NM_001105659.1), while the der(X) breakpoint mapped
~87kb upstream the POU class 3 homeobox 4 (POU3F4) gene (OMIM-300039)
(NM_000307.4) (Fig 1C; Table 1). Mutation screening revealed no variants in the coding
sequence of POU3F4 apart from two benign single nucleotide polymorphisms (rs5921978 and
rs5921979; S1 Fig). In addition, RT-PCR analysis revealed absence of POU3F4 expression in
the patient as compared with a normal control (Fig 1D). Finally, a highly skewed X-inactiva-
tion pattern (100:0) was observed in Case 1 after pre-digestion with the methylation-sensitive
restriction enzyme HpaII (Fig 1E).
Case 2—46,XX,t(6;7;8;12)(p22.2;q31.3;q24.3;q13.1)dn
Case 2 is an affected female presenting with mild to moderate intellectual disability (ID). Initial
G-banding and FISH analyses detected a de novo apparently balanced CCR involving chromo-
somes 6, 7, 8, and 12, and seven breakpoints [11]. Previous array-CGH revealed a heterozygous
Table 1. Translocation breakpoints as identified by Whole-Genome Mate-Pair Sequencing and validated by Sanger sequencing (hg19).
Translocation junctions as
estimated by WG-MPS
Junction
Length
Translocation breakpoint position as
defined by SS
Disrupted Genes Insertions/deletions
(+ strand)
Microhomology
(+ strand)
Case 1—Female with hearing loss
chr1:74499775–74500253 479bp chr1:74500101–74500108 LRRIQ3 AATTCA duplication AATTC
chrX:82675876–82676282 407bp chrX:82676074–82676079 ~87kb upstream
POU3F4
GAATT duplication
G deletion
GAATT
Case 2—Female with mild to moderate intellectual disability
chr6:16754266–16755111 845bp chr6:16754305–16754306 ATXN1 ND -
chr7:120530428–120531641 1214bp chr7:120530522–120530523 - ND G
chr7:124121849–124122971 1123bp chr7:124122363–124122371 - ATCTTTT deletion
T insertion
-
chr8:129588349–129589617 1269bp chr8:129589008–129589009 - ND CTGG
chr8:132602314–132603246 933bp chr8:132602994–132602995 - - -
chr8:132899241–132900431 1191bp chr8:132899713–132899714 - T insertion -
chr8:132937706–132938936 1231bp chr8:132938698–132938699 EFR3A ND -
chr12:24016019–24017286 1268bp chr12:24016112–24016113 SOX5 ND C
chr12:27177142–27177824 682bp chr12:27177486–27177487 MED21 ND -
chr12:55357036–55357802 767bp chr12:55357553–55357554 TESPA1 ND CCAG
chr12:65386366–65387285 920bp chr12:65386836–65386837 - ND -
chr12:68784020–68784572 553bp chr12:68784362–68784363 - ND -
Case 3—Female with dysmorphic facial features and speech delay
chr4:118195375–118197310 1936bp chr4:118195456–118195460 - AGG duplication G
chr9:14104333–14104994 662bp chr9:14104378–14104384 NFIB GTCTA deletion -
The junction length, disrupted genes, as well as insertions/deletions and microhomology at the breakpoint junctions are also given. In Case 2, only those translocation
breakpoint junctions mapped to the base-pair level are included in Table 1. Due to the highly repetitive regions at most chromothripsis rearrangement breakpoints in
Case 2, validation was not feasible for all breakpoint junctions, and hence, possible insertions/deletions could not be determined in most cases. (bp = base-pairs; dn = de
novo; WG-MPS = Whole-Genome Mate-Pair Sequencing; ND = not determined; SS = Sanger sequencing)
https://doi.org/10.1371/journal.pone.0205298.t001
Disease mechanisms in de novo apparently balanced translocations
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Fig 1. Summarized karyotype, WG-MPS, Sanger sequencing, RT-PCR and X-inactivation results from Case 1. A)
Partial ideograms showing the normal and derivative (der) chromosomes (chr) X (purple) and 1 (orange) (not to scale) in
Case 1. Xq13 and 1p31 breakpoints are indicated by arrows. B) Derivative translocation junction sequences (middle line)
and matching reference sequences (top and bottom lines) as identified by Sanger sequencing. Microhomology is
highlighted in yellow, deleted sequences are underlined, and duplicated sequences are in bold letters. C) Schematic
illustration of the Topologically Associated Domain (TAD) structure at the POU3F4 locus (indicated with a dashed line and
Disease mechanisms in de novo apparently balanced translocations
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deletion on chromosome 8q24.22; arr[GRCh37] 8q24.22(131465786_132161678)x1, overlap-
ping the adenylate cyclase 8 (ADCY8) (OMIM-103070) gene. This chr8 deletion was also iden-
tified from the depth of coverage analysis in this study, which additionally detected a patient-
specific ~108kb heterozygous deletion on 12p12.1 overlapping exons 1–3 of the SRY-box 5
(SOX5) gene (OMIM-604975) (NM_006940.4) (Fig 2A). Interestingly, by using WG-MPS,
cryptic complexity and a chromothripsis rearrangement was revealed including thirty-eight
interchromosomal and intrachromosomal translocation junctions in total (Fig 2A) (Table 1;
S2 Table). After accurate derivative chromosome reconstruction of the complex rearrange-
ment (Fig 2B), a number of translocation breakpoints (marked with a black asterisk in Fig 2B)
were validated by Sanger sequencing (Fig 2C; Table 1). In the remaining translocation break-
point junctions, sequence-specific PCR primer design was challenging as most were spanning
very long repeats. In some of these cases, a PCR product was obtained by long-range PCR;
however, breakpoint mapping to the base-pair level with Sanger sequencing was not feasible
(marked with a red asterisk in Fig 2B).
Case 3—46,XX,t(4;9)(q26;p24)dn
Case 3 is a female patient presenting with dysmorphic facial features and speech delay. Initial
karyotype analysis detected a de novo apparently balanced t(4;9)(q26;p24) translocation (Fig
3A). FISH analysis confirmed the rearrangement, while array-CGH at 1MB resolution revealed
no chromosomal imbalances. In the present study, WG-MPS followed by Sanger sequencing
accurately detected the t(4;9) translocation and mapped both breakpoints (Fig 3B; Table 1).
The der(4) breakpoint did not disrupt any genes, whereas the der(9) breakpoint directly dis-
rupted intron 10/10 of the Nuclear Factor I B (NFIB) gene (OMIM-600728)
(NM_001190737.1) (Fig 3C).
Discussion
In contrast to our recent findings concerning familial cases with identical ABTs and discordant
phenotypes [15], breakpoint mapping results from the present study demonstrated that trans-
locations appear to be correlated with phenotype presentation in de novo ABT cases. This is
achieved through a number of underlying molecular mechanisms including LRPE, cryptic
complexity, and direct disease-associated gene disruption by the translocation breakpoints.
In the ABT Case 1 with hearing loss and a t(X;1) translocation, WG-MPS mapped the der
(X) breakpoint ~87kb upstream the POU3F4 gene (also known as Brain-4 or BRN-4)
(NM_000307.4) (Fig 1C; Table 1). This gene encodes for the POU domain, class 3, transcrip-
tion factor 4, which is important for the development of the inner ear [21]. Missense, non-
sense, and frameshift variants as well as deletions overlapping the POU3F4 gene have been
identified in patients with X-linked recessive deafness [22–24]. Structural variants upstream
the coding POU3F4 region, including microdeletions, inversions, and duplications, have also
a blue bar) as created by the 3D Genome Browser (http://promoter.bx.psu.edu/hi-c/). Each dot within individual TADs
reflects the interaction between two DNA positions. The corresponding region from the UCSC Genome Browser was
aligned underneath the heat map. This illustrates among other genes POU3F4 (red rectangle), the der(X) breakpoint
identified in the current study mapping ~87kb upstream POU3F4 (vertical red arrow), as well as specific enhancers
identified by Naranjo et al., 2010 upstream POU3F4 (red vertical bars). D) RT-PCR results showing absence of POU3F4
expression in the patient as compared with a normal control. cDNA = RNA reverse transcribed; RNA = RNA not reverse
transcribed; H2O = no template sample. E) X-inactivation analysis results showing a skewed X-inactivation pattern (100:0).
A PCR product is obtained only from the inactive (methylated) chromosomes. After HpaII digestion, only one peak was
shown in the female patient, whereas, no peak was observed in the male control.
https://doi.org/10.1371/journal.pone.0205298.g001
Disease mechanisms in de novo apparently balanced translocations
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Fig 2. Summarized WG-MPS and Sanger sequencing results in Case 2. A) Circos plot illustrating partial chr6, chr7,
chr8, and chr12 ideograms (outer circle), deletions (red) and duplications (blue) based on the depth of coverage
analysis (inner circle) as well as inter-translocation (green lines) and intra-translocation (purple lines) junctions
identified by WG-MPS in Case 2. SOX5 disruption by a heterozygous deletion and two inter-translocation breakpoints
is highlighted. B) Derivative chromosome reconstruction of the chromothripsis rearrangement. Fragments from
chromosomes 6, 7, 8, and 12 are in red, green, blue, and yellow, respectively. Arrows: fragment orientations; black
Disease mechanisms in de novo apparently balanced translocations
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been reported in patients with similar hearing loss phenotypes, thus indicating the presence of
cis-regulatory elements (e.g. enhancers) within those regions (even up to 900kb upstream),
which if disturbed result in altered POU3F4 expression through LRPE [25–27]. The majority
of POU3F4 disruption cases have been reported in affected males. In contrast, female carriers
are rarely reported, and in these cases, normal, late-onset, or progressive mild to moderate
hearing loss is usually observed [28]. This is due to the presence of a second, normal X-chro-
mosome in females and random X-inactivation; however, in the case of non-random or
skewed X-inactivation, mild symptoms or clinical phenotypes resembling those seen in
affected males are also observed in heterozygous female carriers [29]. To the best of our knowl-
edge, Case 1 is the second female patient reported carrying an X-autosome translocation, with
asterisks: translocation junctions sequenced to the base-pair level; red asterisks: translocation junctions amplified but
not sequenced. C) Derivative translocation junction sequences (middle line) and matching reference sequences (top
and bottom lines) as identified by Sanger sequencing in Case 2. Microhomology is highlighted, and inserted sequences
not aligning to either chromosome are in lower-case letters.
https://doi.org/10.1371/journal.pone.0205298.g002
Fig 3. Summarized WG-MPS and Sanger sequencing results in Case 3. A) Partial ideograms showing the normal and derivative
(der) chromosomes (chr) 4 (dark purple) and 9 (brown) (not to scale) in Case 3. 4q26 and 9p24 breakpoints are indicated by arrows.
B) Derivative translocation junction sequences (middle line) and matching reference sequences (top and bottom lines) as identified
by Sanger sequencing. Microhomology is highlighted in yellow, deleted sequences are underlined, duplicated sequences are in bold
letters, and inserted sequences not aligning to either chromosome are in lower-case letters. C) IGV screenshot illustrating the der(9)
breakpoint disrupting the NFIB gene within intron 10/10 (NM_001190737.1).
https://doi.org/10.1371/journal.pone.0205298.g003
Disease mechanisms in de novo apparently balanced translocations
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the der(X) breakpoint mapping upstream the POU3F4 gene [30]. A highly skewed X-inactiva-
tion pattern was observed in Case 1 (Fig 1E); even though the X-inactivation analysis does not
provide information on the identity of the inactivated chromosome, a favourable inactivation
of the normal, non-translocated X chromosome is hypothesized. This was supported by the
absence of a PCR product after amplification of the patient’s cDNA with POU3F4 primer pairs
(Fig 1D). Collectively, we suggest that the t(X;1) translocation in Case 1 disrupts the TAD
structure of the POU3F4 locus by physically dissociating the gene from important upstream
otic enhancers regulating its expression (Fig 1C) [31]. Thus, absence of a functional POU3F4
gene, caused by LRPE and skewed X-inactivation, underlies hearing loss seen in the ABT
Case 1.
In the ABT Case 2 presenting with mild to moderate ID, WG-MPS detected cryptic rear-
rangement complexity including thirty-eight translocation breakpoints (Fig 2; S2 Table). Such
complex chromosomal profiles resemble those seen in chromothripsis during which a single
catastrophic event occurs followed by rearrangement of the broken segments in a random
order and orientation [32]. In addition, depth of coverage analysis detected a heterozygous
12p12.1 deletion covering exons 1–3 of the SOX5 gene (NM_006940.4) and flanking two trans-
location breakpoints (Fig 2A). This deletion was missed by previous array-CGH, highlighting
the power of low-coverage WG-MPS in identifying smaller deletions below the resolution of
detection of array-CGH. The SOX5 gene encodes for the SRY-box 5 protein; which is involved
in the generation of the cranial neural crest and the proper development of corticofugal neu-
rons [33,34]. Heterozygous 12p12 deletions and a reciprocal t(11;12) translocation disrupting
either SOX5 alone or SOX5 together with other genes have been reported in patients presenting
with ID, global developmental delay, language and motor impairment, and mild dysmorphic
facial features [35], which collectively characterize the neurodevelopmental disorder Lamb-
Shaffer syndrome (OMIM-616803). SOX5 is predicted as extremely intolerant to loss of func-
tion and copy number variants (pLI = 1.00) with a haploinsufficiency score of 0.74% [4]. The
above together with a report by Lelieveld et al. (2016) identifying SOX5 as a new ID gene from
a meta-analysis of 2,104 whole-exome sequencing trios [36], strongly support that the ID phe-
notype in Case 2 is due to SOX5 haploinsufficiency caused by the cryptic chromothripsis
rearrangement.
In the ABT Case 3 with dysmorphic facial features, speech delay and a t(4;9)(q26;p24) trans-
location, WG-MPS successfully mapped the der(9) breakpoint directly within intron 10/10 of
the NFIB gene (NM_001190737.1). NFIB encodes for Nuclear Factor I/B, a cellular transcrip-
tion factor involved in lung maturation and brain development [37]. Additional studies dem-
onstrated another important role of NFIB in the development of the pons, which is part of the
brainstem, and pontine nuclei involved in the motor regulation of facial expressions, chewing,
and swallowing [37,38]. In Latin, pons literally means bridge resembling its function serving as
a connection between different parts of the brain, including the cerebral cortex and the cere-
bellum, both of which have important roles in speech development, as well as language- and
other communication-related functions [39,40]. Since the pons is involved in the regulation of
two main speech processes, i.e. respiration (mediated by the lungs) and articulation (mediated
by movements of the jaw and mouth), it is therefore hypothesized that NFIB heterozygous dis-
ruption by the t(4;9) translocation causing dysfunction of the pons could underlie speech
delay in Case 3. NFIB expression should be investigated next to determine the functional
impact of the translocation; however, since its expression is very low in lymphocytes, an alter-
native tissue suitable to carry out this test cannot be obtained. Finally, a brain MRI would aid
to visualize any hypodevelopment of the pons, thus further supporting a possible functional
association between NFIB disruption and speech delay in Case 3.
Disease mechanisms in de novo apparently balanced translocations
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In conclusion, WG-MPS utilized in this study proved to be a highly powerful universal
method allowing rapid mapping of ABT breakpoints as well as identification of additional
structural variants, independent of the chromosomes involved each time. Results from our
recently published paper, demonstrated that translocations are coincidental and unrelated to
phenotype presentation in the majority of familial ABT carriers with identical rearrangements
and differential phenotypes [15]. In contrast, in line with previous reports and as demon-
strated here, de novo translocations usually occur within or close to pathogenic genes and they
seem to be associated with phenotype presentation in affected carriers via cryptic complexity,
LRPE, and direct gene disruption. Collectively, this study highlights the efficacy of low cover-
age WG-MPS in accurately characterizing ABT breakpoints in both coding and non-coding
regions, and suggesting underlying molecular mechanisms for phenotype association, thus
supporting its potential introduction in the clinical investigation of ABTs.
Supporting information
S1 Table. List of PCR primers used for translocation breakpoint validation. The primer
name, sequence, and melting temperature for each primer used for translocation breakpoint
validation is given. The annealing temperature and extension time used as well as the approxi-
mate size of each amplicon, as compared with either a 100bp or 1kb DNA ladder, are also
given.
(DOCX)
S2 Table. Translocation breakpoint junctions of the chromothripsis rearrangement as
identified by whole-genome mate-pair sequencing in Case 2. In the chromothripsis rear-
rangement, each translocation breakpoint split the chromosome into two fragments onto
which fragments from the same or other chromosomes were joined onto. The table below
includes the translocation breakpoint junctions on each chromosome as estimated by
WG-MPS (1st column), the junction length (2nd column), as well as the translocation break-
point junction fragments (3rd column) that joined on the left and right side of each fragment.
In addition, the joining fragment pairs as illustrated in Fig 2B (4th column) as well as fragment
orientations (5th column) are also given. Forward-Forward (FF) and Reverse-Reverse (RR)
orientations indicate that one of the two joining fragments has been inverted.
(DOCX)
S1 Fig. POU3F4mutation screening results in Case 1. A) Sanger sequencing electrophero-
gram screenshot illustrating the two benign POU3F4 SNPs identified in Case 1 (red arrows).
B) Pairwise alignment of the nucleotide sequence including the two SNPs (bottom line) and
the corresponding reference sequence (top line). The two mismatches indicating the SNP posi-
tions are indicated with dots.
(PDF)
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